Market Update: Dr. Reddy’s Laboratories Limited
As of May 12, 2026, the market for Dr. Reddy’s Laboratories Limited has seen some fluctuations. The last recorded price for the stock is 1,270.10 INR, showing a decrease of 0.75% from the previous day. The comparison to January 1 shows a slight drop of 0.07%.
Daily Market Overview
- Current Time: 06:18 AM EDT
- 5-Day Change: -0.75%
- Year-to-Date Change: -0.07%
Key Highlights:
Dr. Reddy’s is a notable player in the pharmaceutical industry, focusing on an extensive range of products, including active pharmaceutical ingredients (APIs), generics, and branded generics. They’ve made significant strides in areas such as oncology, cardiology, and pain management.
Stock Charts
For those interested in tracking the stock’s daily performance, an intraday chart can provide visual insights into recent trends.
Investor Sentiment
Currently, there is a cautious sentiment among investors regarding the company, with consensus ratings suggesting a moderate sell position. The last closing price was 1,279.70 INR, while the average target price stands at approximately 1,328.95 INR.
Company Insights
Dr. Reddy’s is dedicated to providing comprehensive healthcare solutions, offering an array of products across different therapeutic areas. The company emphasizes quality and regulatory compliance, ensuring that it plays a vital role in patient health.
For further updates and details, stakeholders and analysts continue to monitor market conditions closely.
